[Antimicrobial therapy in cancer patients and hematopoietic stem cell transplantation receptors]

Rev Chilena Infectol. 2019 Apr;36(2):167-178. doi: 10.4067/S0716-10182019000200167.
[Article in Spanish]

Abstract

This manuscript includes the antiinfective therapeutic resources for immunocompromised patients under chemotherapy by cancer or hematopoietic stem cells transplant (HSCT) receptors. The document presents the antimicrobial therapy indicated in the most prevalent clinical situations in this population and the primary and alternative therapy for some specific microorganisms. The clinical situations included in the analysis are: febrile neutropenia without focus, sepsis, infections of the central nervous system, pneumonia, skin and soft tissue infections, neutropenic enterocolitis and urinary tract infection. The therapeutic resources, recommended doses and special precautions for the use of antimicrobial recommended in bacterial, viral, fungal and parasitic infections in this population are described, including the measurement of plasma concentrations of certain drugs in specific situations.

MeSH terms

  • Anti-Infective Agents / administration & dosage*
  • Dose-Response Relationship, Drug
  • Febrile Neutropenia / drug therapy*
  • Hematopoietic Stem Cell Transplantation / adverse effects*
  • Humans
  • Immunocompetence / drug effects
  • Immunocompromised Host / drug effects
  • Infections / drug therapy*
  • Neoplasms / complications*
  • Neoplasms / therapy*
  • Practice Guidelines as Topic
  • Risk Factors
  • Treatment Outcome

Substances

  • Anti-Infective Agents